ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Swiss lab develops genetic tool kit to turn any cell into a tumor killer – Ars Technica

Continue reading

2017-11-17 Michael Zand NEWS

Lab-Grown Synthetic Nanobots May Officially End Antibiotic Resistance – Futurism

FuturismLab-Grown Synthetic Nanobots May Officially End Antibiotic ResistanceFuturismResearchers have begun to consider synthetic biology as a new way to combat harmful bacteria. By creating their own microbes, researchers could provide targeted soluti… Continue reading

2017-11-17 Michael Zand NEWS

Biodesix Pushes Back Immunotherapy Test Development Timeline – GenomeWeb

Biodesix Pushes Back Immunotherapy Test Development TimelineGenomeWebNEW YORK (GenomeWeb) – Biodesix is pushing back the timeline for its immunotherapy test development program as it works to assess what clinical questions are likely to be the biggest … Continue reading

2017-11-17 Michael Zand NEWS

What We’re Reading: Gene Therapy Guidelines; Opioid Overdose Costs; Unaware of Open Enrollment – AJMC.com Managed Markets Network


Ars Technica

Swiss lab develops genetic tool kit to turn any cell into a tumor killer
Ars Technica
We’ve made some impressive advances toward inducing the immune system to attack cancers. One of these techniques, using CAR–T cells, is amazing. CAR–T cells are made by inserting receptors that recognize cancerous cells into a leukemia patient’s own …

and more »

Continue reading

2017-11-17 Michael Zand NEWS

Type 1 diabetes: Could modified blood stem cells lead to a cure? – Medical News Today

What We’re Reading: Gene Therapy Guidelines; Opioid Overdose Costs; Unaware of Open Enrollment
AJMC.com Managed Markets Network
The FDA issued new guidelines to speed up the review process for gene therapies; a new report calculates the potential societal benefits of eliminating the opioid epidemic; and one-third of Americans are unaware that the ACA’s open enrollment season …

Continue reading

2017-11-17 Michael Zand NEWS

Celgene CAR-T Therapy Gets Breakthrough Therapy Designation – Nasdaq

Celgene CAR-T Therapy Gets Breakthrough Therapy DesignationNasdaqCelgene CorporationCELG and partner bluebird bio, Inc. BLUE announced that their chimeric antigen receptor T-cell (CAR-T) therapy candidate, bb2121 targeting b-cell maturation antigen (… Continue reading

2017-11-17 Michael Zand NEWS

Adult Stem Cells and Gene Therapy Save a Young Boy With Horrible Skin Condition – LifeNews.com

LifeNews.comAdult Stem Cells and Gene Therapy Save a Young Boy With Horrible Skin ConditionLifeNews.comWhen people talk about something that “saved their skin,” they usually mean that it helped them out of a difficult situation. But a young boy in Germ… Continue reading

2017-11-17 Michael Zand NEWS

CRISPR patent wars highlight problem of granting broad intellectual property rights for tech that offers public benefits – Phys.Org

Phys.OrgCRISPR patent wars highlight problem of granting broad intellectual property rights for tech that offers public benefitsPhys.OrgCRISPR-Cas9 is a cutting-edge gene editing technique. It has been in the news as many researchers are using it to co… Continue reading

2017-11-17 Michael Zand NEWS
  • 1
  • …
  • 874
  • 875
  • 876
  • 877
  • 878
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Medical News Today

Type 1 diabetes: Could modified blood stem cells lead to a cure?
Medical News Today
Researchers led by those at Harvard Medical School’s Boston Children’s Hospital in Massachusetts found that they could reverse hyperglycemia in diabetic mice by modifying their defective blood stem cells to increase production of a protein called PD-L1.

and more »